Latest filing published 24 Feb 2026 for OCULAR THERAPEUTIX, INC, €23k. Read the official filing
Nadia Waheed is a declared insider of Ocular Therapeutix, Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 1 June 2024 to 20 February 2026, the count stands at 7 filings.
Sales make up the whole of the open-market record (3 sales, €180k). Besides market trades, the filings include 4 share grants. 2026 to date brings no purchases and 2 sales.
The latest filing, published on 24 February 2026, reports an open-market sale of €23k in Ocular Therapeutix, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations